07.01.03
After months of uncertainty regarding the fate of Rexall, the decision was finally made by Royal Numico, Zoetermeer, The Netherlands, to sell the faltering supplement business to NBTY, Bohemia, NY, for $250 million in cash. The addition of Rexall’s business to NBTY’s portfolio greatly increases the company’s variety of products and expands manufacturing capabilities, according to NBTY chairman and CEO Scott Rudolph. The sale of Rexall to NBTY leaves Numico to focus on its core strengths including baby food, clinical nutrition and its GNC business.